Adverse Drug Reactions: Building Drug Safety Beyond Marketing Authorisation
Marketing authorisation is a regulatory conclusion that, on the basis of the available evidence, the medicine has a favourable benefit–risk balance for a defined population and indication [...]
Authors
- Andrej Belančić (ORCID: https://orcid.org/0000-0001-7848-6600)
- Ivana Mudnić (ORCID: https://orcid.org/0000-0003-4169-2886)
Institutions
- University of Rijeka (HR)
- University of Split (HR)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2026-09-10
- DOI
- https://doi.org/10.3390/jcm15186994
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00